Severity profiles of substance-abusing patients in Italian community addiction facilities: Influence of psychiatric concurrent disorders

European Addiction Research

Volumn 12, Issue 2, 2006, Pages 96-101

  Carrà, Giuseppe ^a   Scioli, Rosangela ^b   Monti, Maria Cristina ^c   Marinoni, Alessandra ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Pavia NHS Mental Health Trust   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Addiction Severity Index; DSM IV; Mental disorders; Substance related disorders

Indexed keywords

AMPHETAMINE; COCAINE; OPIATE;

ADDICTION; ADULT; ARTICLE; CASE CONTROL STUDY; COMMUNITY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG DEPENDENCE; FAMILY; FEMALE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; ITALY; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; SKILL; SOCIAL ASPECT; SUBSTANCE ABUSE;

ADULT; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN DEPENDENCE; HUMANS; ITALY; MALE; MENTAL DISORDERS; NEEDS ASSESSMENT; PERSONALITY ASSESSMENT; STATISTICS; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 33645000049     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090429     Document Type: Article

References (32)

1. Kessler RC: The epidemiology of dual diagnosis. Biol Psychiatry 2004;56:730-737.
2. Moos RH, King MJ, Paterson MA: Outcomes of residential treatment of substance abuse in hospital and community-based programs. Psychiatr Serv 1996;47:68-74.
3. Drake RE, Mueser KT, Clarke RE, Wallach MA: The course, treatment and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry 1996;66:42-51.
4. Weaver T, Stimson G, Tyrer P, Barnes T, Renton A: What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations? Drugs Educ Prev Policy 2004;11:329-348.
5. Verthein U, Degkwitz P, Haasen C, Krausz M: Significance of comorbidity for the long-term course of opiate dependence. Eur Addict Res 2005;11:15-21.
6. Hunt GE, Bergen J, Bashir M: Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002;54:253-264.
7. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H: Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002;53:861-867.
8. RachBeisel J, Scott J, Dixon L: Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv 1999;50:1427-1434.
9. Drake RE, McHugo GJ, Clarke RE, Teague GB, Xie H, Miles K, Ackerson TH: Assertive community treatment for patients with co-occurring severe mental illness and substance use disorders: a clinical trial. Am J Orthopsychiatry 1998;68:201-215.
10. Drake RE, Mueser KT, Brunette MF, McHugo GJ: A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 2004;27:360-374.
11. Havassy BE, Alvidrez J, Owen KK: Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry 2004;161:139-145.
12. Jeffery DP, Ley A, McLaren S, Siegfried N: Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Review. Cochrane Library, Issue 1. Chichester, Wiley, 2004.
13. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, Kuipers E: Drug and alcohol problems among individuals with severe mental illness in South London. Br J Psychiatry 1996;168:612-619.
14. Frischer M, Akram G: Prevalence of co-morbid mental illness and drug use recorded in general practice: preliminary findings from the General Practice Research Database. Drugs Educ Prev Policy 2001;8:275-280.
15. Manning VC, Strathdee G, Best D, Keaney F, McGillivray L, Witton J: Dual diagnosis screening: preliminary findings on the comparison of 50 clients attending community mental health services and 50 clients attending community substance misuse services. J Substance Use 2002;7:221-228.
16. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C, Comorbidity of Substance Misuse and Mental Illness Collaborative (Cosmic) study team: Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003;183:304-313.
17. Krausz M, Degkwitz P, Kuhne A, Verthein U: Comorbidity of opiate dependence and mental disorders. Addict Behav 1998;23:767-783.
18. Cantor-Graae E, Nordstroem LG, McNeil TF: Substance abuse in schizophrenia: a review of literature and a study of correlates in Sweden. Schizophr Res 2001;48:69-82.
19. Vanderplasschen W, Rapp RC, Wolf JR, Broekaert E: The development and implementation of case management for substance use disorders in North America and Europe. Psychiatr Serv 2004;55:913-922.
20. Clerici M, Carrà G: 36-month follow up of opiate dependents in three levels of treatment intensity; in: Carrà G, Clerici M (eds): Dual Diagnosis: Filling the Gap. Montrouge, Libbey Eurotext, 2003, pp 85-91.
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
22. First MB, Williams JB, Gibbon M, Spitzer RL: Structured Clinical Interview for DSM-IV AXIS I Disorders, Clinician Version. Washington, American Psychiatric Press, 1997.
23. First MB, Williams JB, Spitzer RL: Structured Clinical Interview for DSM-IV AXIS II Personality Disorders. Washington, American Psychiatric Press, 1997.
24. Kokkevi A, Hartgers C: Europ-ASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1995;1:208-210.
25. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M: The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
26. Stata Corporation: Stata Statistical Software: Release 7.0. College Station, Stata, 2001.
27. Farrell M, Howes S, Taylor C, Lewis G, Jenkins R, Bebbington P, Jarvis M, Brugha T, Gill B, Meltzer H: Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Int Rev Psychiatry 2003;15:43-49.
28. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71-80.
29. Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A: The prevalence and management of mental illness and substance misuse co-morbidity in current mental health and substance misuse treatment populations. Drug Alcohol Rev 2001;20:407-416.
30. Schaar I, Öjehagen A: Severely mentally ill substance abusers: an 18-month follow-up study. Soc Psychiatry Psychiatr Epidemiol 2001;36:70-78.
31. Carrà G, Clerici M: The Italian Association on Addiction Psychiatry (SIPDip), formerly the Italian Association on Abuse and Addictive Behaviours. Addiction 2003;98:1039-1042.
32. Johnson S: Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? Br J Psychiatry 1997;171:205-208.